|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000131668 |
Summary for BARX1 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000131668 | Gene symbol | BARX1 |
| Gene name | BARX homeobox 1 | |
| HGNC | 955 | |
| Entrez ID | 56033 | |
| Gene type | protein_coding | |
| Synonyms | BARX1| | |
| UniProtAcc | Q9HBU1 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for BARX1 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| BARX1 | 7.17e+01 | -4.63e+00 | 7.56e-01 | -6.12e+00 | 9.46e-10 | 2.71e-07 | BRCA |
| BARX1 | 2.96e+02 | -1.41e+00 | 3.89e-01 | -3.63e+00 | 2.83e-04 | 3.61e-03 | SARC |
| BARX1 | 9.11e+01 | 1.20e+00 | 3.28e-01 | 3.66e+00 | 2.57e-04 | 3.65e-02 | PAAD |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| BARX1 | 4.63e+02 | 1.30e+00 | 3.80e-01 | 3.50e+00 | 5.40e-04 | 1.30e-03 | HNSC |
| BARX1 | 4.56e+02 | -2.76e+00 | 8.53e-01 | -3.23e+00 | 1.23e-03 | 7.37e-03 | ESCA |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| BARX1 | 6.77e+01 | 1.77e+00 | 2.42e-01 | 7.31e+00 | 2.70e-13 | 6.79e-13 | BRCA |
Top |
Sex-biased somatic mutation for BARX1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for BARX1 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg14127859 | chr9:93954646 | CGI:chr9:93951044-93955904 | promoter,gene body | 4.47e-01 | 6.00e-01 | -2.37e+00 | 1.77e-02 | 3.34e-02 | -1.53e-01 |
| BRCA | cg00418027 | chr9:93954716 | CGI:chr9:93951044-93955904 | promoter,gene body | 2.80e-01 | 4.01e-01 | -2.01e+00 | 4.43e-02 | 4.78e-02 | -1.20e-01 |
| BRCA | cg05385163 | chr9:93955067 | CGI:chr9:93951044-93955904 | promoter,exon,CDS,gene body | 2.64e-01 | 4.26e-01 | -2.39e+00 | 1.71e-02 | 3.29e-02 | -1.62e-01 |
| GBM | cg13773631 | chr9:93953561 | CGI:chr9:93951044-93955904 | promoter,gene body | 2.22e-01 | 3.43e-01 | -2.53e+00 | 1.15e-02 | 2.66e-02 | -1.20e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg14127859 | chr9:93954646 | CGI:chr9:93951044-93955904 | promoter,gene body | 3.75e-01 | 2.56e-01 | 3.91e+00 | 9.33e-05 | 1.92e-04 | 1.19e-01 |
| THCA | cg17354303 | chr9:93954383 | CGI:chr9:93951044-93955904 | promoter,gene body | 5.37e-01 | 4.30e-01 | 3.18e+00 | 1.46e-03 | 4.11e-03 | 1.07e-01 |
| LUSC | cg14127859 | chr9:93954646 | CGI:chr9:93951044-93955904 | promoter,gene body | 4.33e-01 | 2.00e-01 | 3.71e+00 | 2.10e-04 | 9.96e-04 | 2.33e-01 |
| LUSC | cg00927495 | chr9:93953405 | CGI:chr9:93951044-93955904 | UTR,promoter,exon,gene body | 3.85e-01 | 1.07e-01 | 3.80e+00 | 1.47e-04 | 8.29e-04 | 2.78e-01 |
| LUSC | cg13773631 | chr9:93953561 | CGI:chr9:93951044-93955904 | promoter,gene body | 4.27e-01 | 1.83e-01 | 3.44e+00 | 5.75e-04 | 1.81e-03 | 2.44e-01 |
| LUSC | cg06071058 | chr9:93953809 | CGI:chr9:93951044-93955904 | promoter,gene body | 5.37e-01 | 2.61e-01 | 4.07e+00 | 4.61e-05 | 5.49e-04 | 2.76e-01 |
| LUSC | cg13808083 | chr9:93954245 | CGI:chr9:93951044-93955904 | promoter,gene body | 5.57e-01 | 3.20e-01 | 3.92e+00 | 8.72e-05 | 6.61e-04 | 2.37e-01 |
| LUSC | cg17354303 | chr9:93954383 | CGI:chr9:93951044-93955904 | promoter,gene body | 5.82e-01 | 3.79e-01 | 4.04e+00 | 5.31e-05 | 5.65e-04 | 2.03e-01 |
| LUSC | cg00418027 | chr9:93954716 | CGI:chr9:93951044-93955904 | promoter,gene body | 3.03e-01 | 1.39e-01 | 3.63e+00 | 2.82e-04 | 1.18e-03 | 1.63e-01 |
| LUSC | cg06288684 | chr9:93956361 | CGI:chr9:93951044-93955904 | promoter | 7.51e-01 | 6.00e-01 | 3.81e+00 | 1.39e-04 | 8.07e-04 | 1.51e-01 |
| BLCA | cg00418027 | chr9:93954716 | CGI:chr9:93951044-93955904 | promoter,gene body | 4.02e-01 | 1.77e-01 | 3.00e+00 | 2.66e-03 | 4.92e-03 | 2.25e-01 |
| BLCA | cg05385163 | chr9:93955067 | CGI:chr9:93951044-93955904 | promoter,exon,CDS,gene body | 3.11e-01 | 1.29e-01 | 2.31e+00 | 2.10e-02 | 2.54e-02 | 1.82e-01 |
| CHOL | cg14127859 | chr9:93954646 | CGI:chr9:93951044-93955904 | promoter,gene body | 4.41e-01 | 1.87e-01 | 2.51e+00 | 1.22e-02 | 2.39e-02 | 2.54e-01 |
| CHOL | cg06071058 | chr9:93953809 | CGI:chr9:93951044-93955904 | promoter,gene body | 4.93e-01 | 2.45e-01 | 2.80e+00 | 5.09e-03 | 1.63e-02 | 2.47e-01 |
| CHOL | cg17354303 | chr9:93954383 | CGI:chr9:93951044-93955904 | promoter,gene body | 5.87e-01 | 3.66e-01 | 3.54e+00 | 4.02e-04 | 8.32e-03 | 2.20e-01 |
| CHOL | cg00418027 | chr9:93954716 | CGI:chr9:93951044-93955904 | promoter,gene body | 2.52e-01 | 1.50e-01 | 1.99e+00 | 4.65e-02 | 4.65e-02 | 1.02e-01 |
| CHOL | cg06288684 | chr9:93956361 | CGI:chr9:93951044-93955904 | promoter | 7.47e-01 | 6.19e-01 | 2.36e+00 | 1.83e-02 | 2.92e-02 | 1.28e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg14127859 | chr9:93954646 | CGI:chr9:93951044-93955904 | promoter,gene body | 4.47e-01 | 2.49e-01 | 9.68e+00 | 3.72e-22 | 2.43e-21 | 1.98e-01 |
| BRCA | cg00927495 | chr9:93953405 | CGI:chr9:93951044-93955904 | UTR,promoter,exon,gene body | 3.26e-01 | 2.13e-01 | 5.86e+00 | 4.56e-09 | 1.05e-08 | 1.13e-01 |
| BRCA | cg06071058 | chr9:93953809 | CGI:chr9:93951044-93955904 | promoter,gene body | 6.14e-01 | 4.41e-01 | 8.45e+00 | 3.00e-17 | 1.30e-16 | 1.73e-01 |
| BRCA | cg13808083 | chr9:93954245 | CGI:chr9:93951044-93955904 | promoter,gene body | 6.40e-01 | 5.33e-01 | 6.48e+00 | 9.09e-11 | 2.40e-10 | 1.08e-01 |
| BRCA | cg17354303 | chr9:93954383 | CGI:chr9:93951044-93955904 | promoter,gene body | 6.37e-01 | 4.92e-01 | 1.11e+01 | 8.73e-29 | 1.10e-27 | 1.45e-01 |
| BRCA | cg00418027 | chr9:93954716 | CGI:chr9:93951044-93955904 | promoter,gene body | 2.80e-01 | 1.72e-01 | 4.64e+00 | 3.50e-06 | 6.15e-06 | 1.08e-01 |
| BRCA | cg05385163 | chr9:93955067 | CGI:chr9:93951044-93955904 | promoter,exon,CDS,gene body | 2.64e-01 | 1.09e-01 | 8.75e+00 | 2.09e-18 | 9.93e-18 | 1.56e-01 |
| LIHC | cg14127859 | chr9:93954646 | CGI:chr9:93951044-93955904 | promoter,gene body | 3.83e-01 | 1.84e-01 | 3.53e+00 | 4.13e-04 | 1.14e-03 | 1.99e-01 |
| LIHC | cg06071058 | chr9:93953809 | CGI:chr9:93951044-93955904 | promoter,gene body | 4.49e-01 | 2.21e-01 | 4.02e+00 | 5.79e-05 | 2.54e-04 | 2.28e-01 |
| LIHC | cg13808083 | chr9:93954245 | CGI:chr9:93951044-93955904 | promoter,gene body | 4.25e-01 | 2.40e-01 | 3.12e+00 | 1.82e-03 | 3.62e-03 | 1.85e-01 |
| LIHC | cg05385163 | chr9:93955067 | CGI:chr9:93951044-93955904 | promoter,exon,CDS,gene body | 2.69e-01 | 1.11e-01 | 2.99e+00 | 2.83e-03 | 5.11e-03 | 1.58e-01 |
Top |
Exon skipping events with PSI in TCGA for BARX1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for BARX1 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for BARX1 |
| TFs related to BARX1. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| SARC | ZNF100 | BARX1 | 3.78e+00 | 1.12e-02 | 4.40e+00 | 9.81e-01 | Female-biased |
| BARX1 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
 |
Top |
Sex-biased RBP-ES network for BARX1 |
| RBPs related to ES in BARX1. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BARX1 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs2417367 | chr9:102494715:A:T | - | 0.152625746113173 | 0.000849980489220805 | BLCA | Female-baised eQTL |
| rs62577380 | chr9:101615469:G:T | - | 0.0892035626908496 | 0.00101381725940692 | LUAD | Female-baised eQTL |
| rs7851338 | chr9:101614130:A:G | - | 0.0865318258706746 | 0.00153803826213194 | LUAD | Female-baised eQTL |
| rs35441547 | chr9:101614662:C:T | - | 0.0865318258706746 | 0.00153803826213194 | LUAD | Female-baised eQTL |
| rs62577396 | chr9:101617718:G:T | - | 0.0945139066497053 | 0.00272285269694363 | LUAD | Female-baised eQTL |
| rs111863667 | chr9:101615449:T:C | - | 0.0786281010952118 | 0.00321829971809993 | LUAD | Female-baised eQTL |
| rs62577381 | chr9:101615639:A:G | - | 0.0786281010952118 | 0.00321829971809993 | LUAD | Female-baised eQTL |
| rs76457315 | chr9:101616843:A:T | - | 0.0900303022781096 | 0.00491748935961378 | LUAD | Female-baised eQTL |
| rs10121465 | chr9:101615213:C:A | - | 0.0730278404196268 | 0.00632722089101331 | LUAD | Female-baised eQTL |
| rs62577382 | chr9:101615844:G:T | - | 0.0872312937650171 | 0.00657034033796393 | LUAD | Female-baised eQTL |
| rs62577383 | chr9:101616028:C:T | - | 0.0872312937650171 | 0.00657034033796393 | LUAD | Female-baised eQTL |
| rs58984022 | chr9:101616244:G:A | - | 0.0872312937650171 | 0.00657034033796393 | LUAD | Female-baised eQTL |
| rs60523933 | chr9:101616265:C:T | - | 0.0872312937650171 | 0.00657034033796393 | LUAD | Female-baised eQTL |
| rs58492917 | chr9:101616485:G:A | - | 0.0872312937650171 | 0.00657034033796393 | LUAD | Female-baised eQTL |
| rs59550329 | chr9:101616615:C:G | - | 0.0872312937650171 | 0.00657034033796393 | LUAD | Female-baised eQTL |
| rs62577392 | chr9:101617320:G:C | - | 0.0872312937650171 | 0.00657034033796393 | LUAD | Female-baised eQTL |
| rs62577393 | chr9:101617577:A:T | - | 0.0872312937650171 | 0.00657034033796393 | LUAD | Female-baised eQTL |
| rs62577394 | chr9:101617628:A:T | - | 0.0872312937650171 | 0.00657034033796393 | LUAD | Female-baised eQTL |
| rs11998854 | chr9:101619388:G:T | - | 0.0871307997085637 | 0.00670786664882055 | LUAD | Female-baised eQTL |
| rs62577398 | chr9:101617784:T:C | - | 0.0805836088749658 | 0.00937616346809709 | LUAD | Female-baised eQTL |
| rs62577402 | chr9:101619914:G:A | - | 0.0838974145735953 | 0.00966860938277378 | LUAD | Female-baised eQTL |
| rs73659569 | chr9:101619938:C:T | - | 0.0838974145735953 | 0.00966860938277378 | LUAD | Female-baised eQTL |
| rs73659570 | chr9:101619951:G:C | - | 0.0838974145735953 | 0.00966860938277378 | LUAD | Female-baised eQTL |
| rs55889755 | chr9:101620173:G:T | - | 0.0838974145735953 | 0.00966860938277378 | LUAD | Female-baised eQTL |
| rs62577404 | chr9:101621268:G:A | - | 0.0838974145735953 | 0.00966860938277378 | LUAD | Female-baised eQTL |
| rs7047606 | chr9:87440415:G:A | - | 0.0740469263258838 | 0.0120894958890618 | LUAD | Female-baised eQTL |
| rs10985825 | chr9:98310561:C:T | - | 0.0517733952025497 | 0.0139806485667245 | LUAD | Female-baised eQTL |
| rs10117679 | chr9:101616197:C:T | - | 0.0750968626452071 | 0.0177149470498015 | LUAD | Female-baised eQTL |
| rs28710967 | chr9:101617180:A:C | - | 0.0750968626452071 | 0.0177149470498015 | LUAD | Female-baised eQTL |
| rs58955229 | chr9:101617236:A:G | - | 0.0750968626452071 | 0.0177149470498015 | LUAD | Female-baised eQTL |
| rs10120369 | chr9:101619432:C:T | - | 0.074999441291282 | 0.0180457655343205 | LUAD | Female-baised eQTL |
| rs41343045 | chr9:101617518:T:C | - | 0.0762998258586068 | 0.0189963755200395 | LUAD | Female-baised eQTL |
| rs10124297 | chr9:101619905:T:A | - | 0.07254458830015 | 0.0235119082287915 | LUAD | Female-baised eQTL |
| rs10120524 | chr9:101620029:C:T | - | 0.07254458830015 | 0.0235119082287915 | LUAD | Female-baised eQTL |
| rs10123684 | chr9:101620151:A:T | - | 0.07254458830015 | 0.0235119082287915 | LUAD | Female-baised eQTL |
| rs10121191 | chr9:101620232:C:T | - | 0.07254458830015 | 0.0235119082287915 | LUAD | Female-baised eQTL |
| rs356664 | chr9:95302247:T:C | - | -0.038472418982933 | 0.0313461660696325 | LUAD | Female-baised eQTL |
| rs80044157 | chr9:96315320:C:T | - | 0.0756631074313575 | 0.0317906947972854 | LUAD | Female-baised eQTL |
| rs473825 | chr9:95306492:C:A | - | -0.0380652687223313 | 0.0335809554676475 | LUAD | Female-baised eQTL |
| rs7022252 | chr9:87459127:G:T | - | 0.0688483924404549 | 0.047627257008016 | LUAD | Female-baised eQTL |
| rs10120552 | chr9:96318180:C:T | - | 0.0802724993295868 | 0.049755527778183 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs12353276 | chr9:91139758:G:A | - | 0.0376532521567488 | 0.0445950147409302 | LUSC | Male-baised eQTL |
| rs4743900 | chr9:93194985:T:C | - | -0.0344560013707416 | 0.049992906583108 | LUSC | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000131668 |
| CpG Site: cg17354303 | |
| Position to Gene: gene,promoter | |
| Male Effect: -0.372696083215133 | |
| Female Effect: - | |
 | Gene ID: ENSG00000131668 |
| CpG Site: cg17354303 | |
| Position to Gene: gene,promoter | |
| Male Effect: -0.149410305842176 | |
| Female Effect: - | |
 | Gene ID: ENSG00000131668 |
| CpG Site: cg17354303 | |
| Position to Gene: gene,promoter | |
| Male Effect: -0.448582954151725 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg17354303 | chr9:93954383 | gene,promoter | -0.372696083215133 | 8.98668874528104e-05 | -0.32787586098906846 | 5.838956436648365e-07 | LUAD |
| cg17354303 | chr9:93954383 | gene,promoter | -0.149410305842176 | 5.29352518741342e-06 | -0.33383675163998644 | 1.3091825420657853e-08 | LUSC |
| cg17354303 | chr9:93954383 | gene,promoter | -0.448582954151725 | 5.32102617883975e-19 | -0.5168690052595859 | 3.112601469539514e-22 | BLCA |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of BARX1 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000131668 | BARX1 | C0279628 | Adenocarcinoma Of Esophagus | 1 | CTD_human |
